Literature DB >> 29784740

NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.

Peter H Carroll1, James L Mohler1.   

Abstract

Peter H. Carroll, MD, MPH, and James L. Mohler, MD, updated attendees on what is new in the 2018 NCCN Guidelines for Prostate Cancer Early Detection and for Prostate Cancer, respectively. Their presentations touched on new screening recommendations, shared decision-making, risk stratification, the role of genomic and molecular testing, active surveillance, and newer systemic treatments.
Copyright © 2018 by the National Comprehensive Cancer Network.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29784740     DOI： 10.6004/jnccn.2018.0036

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  77 in total

1.  Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.

Authors:  Brandon A Mahal; Santino Butler; Idalid Franco; Daniel E Spratt; Timothy R Rebbeck; Anthony V D'Amico; Paul L Nguyen
Journal:  JAMA       Date:  2019-02-19       Impact factor: 56.272

2.  Factors associated with appropriate and low-value PSA testing.

Authors:  Nathaniel Oswald; Tengda Lin; Benjamin Haaland; Michael Flynn; Kensaku Kawamoto; Kathleen A Cooney; William Lowrance; Heidi A Hanson; Brock O'Neil
Journal:  Cancer Epidemiol       Date:  2020-05-08       Impact factor: 2.984

Review 3.  Conceptual review of key themes in treating prostate cancer in older adults.

Authors:  Ramy Sedhom; Arjun Gupta
Journal:  J Geriatr Oncol       Date:  2019-11-05       Impact factor: 3.599

4.  External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomy.

Authors:  Sophie Knipper; David Pröwrock; Zhe Tian; Hans Heinzer; Derya Tilki; Pierre Karakiewicz; Markus Graefen
Journal:  World J Urol       Date:  2019-03-04       Impact factor: 4.226

5.  Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and Communication.

Authors:  Roman Gulati; Sarah P Psutka; Ruth Etzioni
Journal:  J Urol       Date:  2019-10-09       Impact factor: 7.450

6.  Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance.

Authors:  Se Young Choi; Bumjin Lim; Yoon Soo Kyung; Yunlim Kim; Bong Min Kim; Byung Hee Jeon; Jae Chan Park; Young Woong Sohn; Jae Hyuk Lee; Ji-Hyun Uh; Seongsoo Jang; Choung-Soo Kim
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

7.  Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.

Authors:  Andrei S Purysko; Cristina Magi-Galluzzi; Omar Y Mian; Sarah Sittenfeld; Elai Davicioni; Marguerite du Plessis; Christine Buerki; Jennifer Bullen; Lin Li; Anant Madabhushi; Andrew Stephenson; Eric A Klein
Journal:  Eur Radiol       Date:  2019-03-07       Impact factor: 5.315

8.  68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study.

Authors:  Lars J Petersen; Julie B Nielsen; Niels C Langkilde; Astrid Petersen; Ali Afshar-Oromieh; Nandita M De Souza; Katja De Paepe; Rune V Fisker; Dennis T Arp; Jesper Carl; Uwe Haberkorn; Helle D Zacho
Journal:  World J Urol       Date:  2019-06-12       Impact factor: 4.226

9.  Combination of 68Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis.

Authors:  Mengxia Chen; Qing Zhang; Chengwei Zhang; Xiaozhi Zhao; Giancarlo Marra; Jie Gao; Xiaoyu Lv; Bing Zhang; Yao Fu; Feng Wang; Xuefeng Qiu; Hongqian Guo
Journal:  J Nucl Med       Date:  2018-12-14       Impact factor: 10.057

10.  External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients.

Authors:  Sophie Knipper; Cristina Dzyuba-Negrean; Carlotta Palumbo; Angela Pecoraro; Giuseppe Rosiello; Zhe Tian; Alberto Briganti; Fred Saad; Derya Tilki; Markus Graefen; Pierre I Karakiewicz
Journal:  Int Urol Nephrol       Date:  2019-09-21       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.